P has delivered one of the more striking moves in storage hardware this month — up 31% on the week and 53% over the past month to close at $118.16 — and the tension entering next week is straightforward: analysts are scrambling to lift targets while the company's founder sells into every up-day.
The analyst upgrade cycle has been unusually concentrated and swift. Five firms moved their targets higher in just four days this week. Citigroup upgraded to Buy with a $118 target, Susquehanna moved to Positive, and Morgan Stanley lifted to Overweight — all citing the same tailwinds around storage demand and a new hyperscaler deal. Guggenheim went furthest, raising its target to $150. Evercore ISI lifted to $120. The consensus mean now sits at roughly $102, well below where the stock is already trading, which tells you how fast the stock has run past the Street's expectations. The lone dissenter remains UBS, holding a Sell with a $70 target — a reading that looks increasingly isolated. The bull case centres on Everpure's cloud and on-premises storage platform gaining share, raised full-year revenue guidance of $4.41–4.51B, and gross margins running above 70%. Bears point to the risk of demand destruction in a softer macro environment and the vulnerability of storage pricing to commodity cycles.
Positioning in the lending market gives shorts nowhere to hide and no particular reason to press. Availability is extraordinarily loose — well above 9,000% — meaning shares to borrow vastly outnumber existing short positions. Cost to borrow is 0.30%, near its lowest level of the past month. Short interest itself has drifted down fractionally on the week to about 3% of the free float, roughly 10 million shares — a level that has been steady for weeks and carries no meaningful squeeze pressure in either direction. Options traders are similarly relaxed: the put/call ratio at 0.66 is slightly below its 20-day average of 0.68, a half-standard-deviation lean toward calls, consistent with a market that is riding the momentum rather than hedging against it. The ORTEX short score at 34.4 is in the lower half of its range, reflecting the absence of any conviction short thesis in the data right now.
The most pointed signal this week comes from inside the company itself. Founder and Executive Director John Colgrove sold approximately 100,000 shares across Tuesday and Wednesday, generating roughly $13 million in proceeds at prices between $108 and $114. That is a significant clip even for a founder who holds nearly 3.6% of the company. The institutional base is broadly supportive — FMR holds 15%, BlackRock 10.4%, and State Street added 424,000 shares — but Colgrove's selling into the rally stands apart from that constructive institutional posture. The 90-day net insider picture shows positive net share count, suggesting this week's sales are part of a planned distribution program rather than a directional call, but the volume and timing are worth tracking.
Earnings are scheduled for August 26. The prior print in late May produced a sharp one-day drop of more than 17% and a five-day loss of 8.5%, even as the company raised guidance — a reminder that in a stock trading at 41x trailing earnings and 17.7x book, execution has to be flawless and the guidance raise has to exceed what the market has already priced in. The June print was far more benign, producing less than a 1% move on the day. With the stock now 31% higher than it was a week ago, the bar for the upcoming release has risen materially. The key variable to watch in the days ahead is whether analyst targets continue to cluster above $120 — validating the current price — or whether the Colgrove selling and the gap between consensus and spot price prompt any of this week's upgraders to revisit their conviction before the number drops.
See the live data behind this article on ORTEX.
Open P on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
